Orexigen Therapeutics Inc
(NASDAQ: OREX)
-0.03
-0.46%
| Shares Outstanding | 95.00 Mil |
| Institutional Ownership (%) | 76.21 |
| Top 10 Institutions (%) | 43.80 |
| Mutual Fund Ownership (%) | 0.39 |
| 5%/Insider Ownership (%) | 41.42 |
| Float (%) | 58.59 |
| DESCRIPTION | # OF HOLDERS | SHARES |
|---|---|---|
| Total Positions | 130 | 72,403,234 |
| New Positions | 25 | 0 |
| Soldout Positions | 68 | 0 |
| Net Position Change | -14 | -603,264 |
| Buyers | 85 | 15,182,189 |
| Sellers | 99 | -15,785,453 |
| MUTUAL FUND | SHS HELD | SHS CHG | %CHG | $CHG* | %OUT | %PORT | RPT DATE |
|---|---|---|---|---|---|---|---|
| American Funds SMALLCAP World Fund | 6,535,000 | 0 | 0 | 6,600,350 | 6.9 | 0.2 | 03-31-13 |
| Fidelity Select Biotechnology Portfolio | 3,436,142 | 1,322,979 | 62.6 | 10,416,143 | 3.6 | 0.5 | 03-31-13 |
| American Funds Insurance Series Global Small Capitalization | 2,445,000 | 2,445,000 | 1 | 15,305,700 | 2.6 | 0.5 | 03-31-13 |
| SPDR S&P Biotech ETF | 1,736,856 | 1,736,856 | 1 | 10,872,719 | 1.8 | 1.4 | 03-31-13 |
| iShares Russell 2000 Index Fund | 1,305,349 | 297,169 | 29.5 | 2,878,540 | 1.4 | 0 | 03-31-13 |
| Vanguard Total Stock Market Index Fund | 925,442 | 57,700 | 6.6 | 1,237,621 | 1 | 0 | 03-31-13 |
| Vanguard Small-Cap Growth Index Fund | 806,541 | 19,997 | 2.5 | 919,591 | 0.8 | 0 | 03-31-13 |
| iShares NASDAQ Biotechnology Index Fund | 770,744 | 114,458 | 17.4 | 1,379,356 | 0.8 | 0.2 | 03-31-13 |
| RS Small Cap Growth Fund | 754,600 | 98,700 | 15 | 1,280,321 | 0.8 | 0.7 | 03-31-13 |
| Prudential Jennison Health Sciences Fund | 744,110 | 0 | 0 | 751,551 | 0.8 | 0.3 | 03-31-13 |
| Vanguard Extended Market Index Fund | 730,643 | 44,350 | 6.5 | 970,787 | 0.8 | 0 | 03-31-13 |
| Franklin Biotechnology Discovery Fund | 678,000 | 71,400 | 11.8 | 1,059,630 | 0.7 | 0.7 | 03-31-13 |
| TIAA-CREF Small Cap Equity Fund | 634,241 | -199,900 | -24 | -605,506 | 0.7 | 0.2 | 02-28-13 |
| UBS (Lux) Equity Fund - Biotech | 633,200 | 0 | 0 | 633,200 | 0.7 | 0.8 | 01-31-13 |
| T. Rowe Price Health Sciences Fund | 625,000 | 0 | 0 | 631,250 | 0.7 | 0.1 | 03-31-13 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.